跳至主要内容
临床试验/NCT00155233
NCT00155233Unknown4 期

Interaction Between Nalbuphine and Morphine in Postoperative PCA for Gynecologic Patients

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2005年1月最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
200
试验地点
2
主要终点
analgesic effect

研究概览

简要总结

  1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist
  2. This study was designed to investigate the interaction between nalbuphine and morphine

详细描述

  1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist
  2. This study was designed to investigate the interaction between nalbuphine and morphine
  3. The analgesic effect and opioid-related side effects will be investigated

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18-65 y/o
  • Female patients of ASA physical status I to III
  • Scheduled for elective abdominal hysterectomy, myomectomy, or excision of ovarian tumor

排除标准

  • Patients with a definite diagnosis of chronic pain syndrome, psychiatric disorders, or drug abuse (include opioids, NSAIDs, sedatives, antidepressants)
  • Intraoperative fentanyl use > 3 μg/kg
  • Patients with definite diagnosis of esophageal reflux syndrome
  • Use of sedatives, antiemetics, or antipruritics within 24 hours before operation
  • Surgery > 4 hours or laparoscopy surgery

结局指标

主要结局

analgesic effect

次要结局

  • incidence of opioid-related side effects

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验